Earnings History Data for IN8bio, Inc. (INAB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
IN8bio, Inc.
IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
08-08-2024 | PM | INAB | IN8bio, Inc. | 31.46 | -0.19 | -0.16 | -0.27 | IN8bio GAAP EPS of -$0.19 [8/9/2024 7:22 AM] |
0.6841 | 0.0 (0.00%) |
0.70 | 0.02 (2.32%) |
0.65 - 2.48 | 43,088 | 80,000 | 2,763 | ||
14-03-2024 | AH | INAB | IN8bio | 41.00 | -0.21 | -0.16 | 0.00 | IN8bio GAAP EPS of -$0.22 [3/14/2024 5:54 PM] |
1.19 | 0.03 (2.59%) |
1.17 | 0.01 (0.86%) |
0.65 - 3.95 | 112,098 | 190,000 | 1,371 | ||
30-03-2023 | PM | INAB | IN8bio, Inc. | 44.10 | -0.32 | -0.28 | -0.21 | IN8bio GAAP EPS of -$0.32 in-line [3/31/2023 12:42 AM] |
1.30 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
1.12 - 4.98 | 23,249 | 80,000 | 0 | ||
12-08-2022 | AH | INAB | IN8bio | 41.00 | -0.38 | -0.33 | 0.00 | IN8bio GAAP EPS of -$0.38 [8/12/2022 4:54 PM] |
1.88 | 0.03 (1.62%) |
1.94 | -0.04 (-2.02%) |
1.84 - 9.50 | 94,120 | 40,000 | 21,442 | ||
12-05-2022 | PM | INAB | IN8bio | 49.00 | -0.33 | -0.34 | 0.00 | IN8bio Q1 GAAP EPS of -$0.33 [5/12/2022 8:31 AM] |
2.25 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
2.00 - 10.32 | 19,127 | 20,000 | 0 | ||
17-03-2022 | AH | INAB | IN8bio, Inc. | 59.08 | -0.21 | 0.00 | 0.00 | IN8bio GAAP EPS of -$0.44 [3/17/2022 4:49 PM] |
2.98 | -0.04 (-1.16%) |
3.02 | 0.0 (0.00%) |
2.44 - 10.32 | 39,115 | 40,967 | 0 | ||
10-11-2021 | AH | INAB | IN8bio | 159.00 | -0.25 | -0.33 | 0.00 | IN8bio reports Q3 results [11/10/2021 5:13 PM] |
8.01 | -0.54 (-6.32%) |
0.0 | 0.0 (0.00%) |
5.76 - 10.32 | 53,548 | 30,000 | 0 | ||
|